Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

An Active-Controlled Early Phase Study of Elpipodect (MK-8189) in Adults With Schizophrenia (MK-8189-005)

ClinicalTrials.gov ID: NCT03055338

Public ClinicalTrials.gov record NCT03055338. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 6:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia

Study identification

NCT ID
NCT03055338
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
224 participants

Conditions and interventions

Interventions

  • Elpipodect Drug
  • Placebo matching MK-8189 Drug
  • Placebo matching risperidone Drug
  • Risperidone Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 7, 2017
Primary completion
Jan 8, 2018
Completion
Jan 8, 2018
Last update posted
Apr 28, 2026

2017 – 2018

United States locations

U.S. sites
28
U.S. states
13
U.S. cities
26
Facility City State ZIP Site status
Woodland International Research Group, LLC ( Site 0001) Little Rock Arkansas 72211
Woodland Research Northwest, LLC ( Site 0014) Rogers Arkansas 72758
CITRIALS ( Site 0013) Bellflower California 90706
Comprehensive Clinical Development ( Site 0049) Cerritos California 90703
Collaborative Neuroscience Network, LLC ( Site 0057) Garden Grove California 92845
Behavioral Research Specialists, LLC ( Site 0006) Glendale California 91206
Synergy East ( Site 0003) Lemon Grove California 91945
NRC Research Institute ( Site 0043) Orange California 92868
CNRI - Los Angeles, LLC ( Site 0026) Pico Rivera California 90660
Artemis Institute for Clinical Research ( Site 0027) San Diego California 92103
Schuster Medical Research Institute ( Site 0032) Sherman Oaks California 91403
Collaborative Neuroscience Network, LLC ( Site 0046) Torrance California 90502
Larkin Community Hospital Behavioral Health Services ( Site 0020) Hollywood Florida 33021
Clinical Research Centers of America, LLC ( Site 0038) Oakland Park Florida 33334
Aspire Health Partners ( Site 0016) Orlando Florida 32810
Radiant Research - Atlanta ( Site 0008) Atlanta Georgia 30328
Atlanta Center For Medical Research ( Site 0056) Atlanta Georgia 30331
Alexian Center for Psychiatric Research ( Site 0015) Hoffman Estates Illinois 60169
Lake Charles Clinical Trials, LLC ( Site 0040) Lake Charles Louisiana 70629
CBH Health, LLC ( Site 0022) Gaithersburg Maryland 20877
Precise Research Centers ( Site 0018) Flowood Mississippi 39232
Psych Care Consultants Research ( Site 0025) St Louis Missouri 63128
St. Louis Clinical Trials, LLC ( Site 0012) St Louis Missouri 63141
Altea Research Institute ( Site 0017) Las Vegas Nevada 89102
Radiant Research -CliniLabs ( Site 0037) New York New York 10019
Midwest Clinical Research Unit ( Site 0041) Dayton Ohio 45417
InSite Clinical Research ( Site 0033) DeSoto Texas 75115
Pillar Clinical Research, LLC ( Site 0004) Richardson Texas 75080

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03055338, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03055338 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →